See more : Keihan Holdings Co., Ltd. (9045.T) Income Statement Analysis – Financial Results
Complete financial analysis of For The Earth Corp. (FTEG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of For The Earth Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Pioneer Bancorp, Inc. (PBFS) Income Statement Analysis – Financial Results
- U.S. Bancorp (USB-PR) Income Statement Analysis – Financial Results
- Fortive Corporation (0IRE.L) Income Statement Analysis – Financial Results
- Universal Technologies Holdings Limited (1026.HK) Income Statement Analysis – Financial Results
- MEMSensing Microsystems (Suzhou, China) Co., Ltd. (688286.SS) Income Statement Analysis – Financial Results
For The Earth Corp. (FTEG)
About For The Earth Corp.
For the Earth Corporation manufactures and sells consumable household products in the United States and internationally. The company provides a range of laundry detergents, household cleansers, fabric softeners, dryer sheets, dishwashing detergents, and other cleaning products under its own and private label in retail chains. It also provides Litter To Go, a disposable cat litter box made from corrugated material that contains ready-to-use litter; and What Odor?, a biodegradable and non-toxic odor-eliminating spray, as well as other pet supplies, including treats and toys, stylish feeders, and odor/stain-eliminating solutions. For the Earth Corporation sells its products to retail customers; industrial customers comprising hotel, nursing homes, restaurants, and professional sports teams; and direct-to consumers. The company was formerly known as Medjet Inc. and changed its name to For the Earth Corporation in January 2011. For the Earth Corporation was founded in 1993 and is headquartered in Phoenix, Arizona.
| Metric | 2022 | 2021 | 2020 | 2019 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 837.88K | 0.00 | 31.22K | 0.00 | 2.65M | 1.03M | 525.00K | 175.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 25.64K | 0.00 | 0.00 | 0.00 | -67.96K | -81.90K |
| Gross Profit | 0.00 | 837.88K | 0.00 | 5.58K | 0.00 | 2.65M | 1.03M | 592.96K | 256.90K |
| Gross Profit Ratio | 0.00% | 100.00% | 0.00% | 17.87% | 0.00% | 100.00% | 100.00% | 112.95% | 146.80% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 721.21K | 2.80M | 1.66M | 1.37M | 1.41M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 1.55M | 5.55K | 460.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 1.55M | 5.55K | 460.29K | 721.21K | 3.11M | 1.66M | 1.43M | 1.49M |
| Cost & Expenses | 0.00 | 1.64M | 5.55K | 485.93K | 721.21K | 3.11M | 1.66M | 1.37M | 1.41M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.70K | 4.08K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 2.12M | 72.66K | 650.66K | 8.67K | 10.37K | 23.21K | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 83.40K | 12.32 | 5.30K | 36.39K | 439.24K | 60.37K | 67.96K | 81.90K |
| EBITDA | 0.00 | -738.97K | -5.55K | -449.42K | -686.44K | -17.99K | -756.66K | -773.71K | -1.15M |
| EBITDA Ratio | 0.00% | -85.41% | 0.00% | -1,439.45% | 0.00% | -12.46% | -104.06% | -149.49% | -657.89% |
| Operating Income | 0.00 | -799.06K | -5.55K | -454.71K | -721.21K | -144.73K | -629.52K | -841.67K | -1.24M |
| Operating Income Ratio | 0.00% | -95.37% | 0.00% | -1,456.42% | 0.00% | -5.46% | -60.97% | -160.32% | -706.01% |
| Total Other Income/Expenses | 0.00 | -2.15M | -72.65K | -650.66K | -7.05K | 306.70K | 717.16K | 11.12K | -2.31K |
| Income Before Tax | 0.00 | -2.95M | -78.21K | -1.11M | -728.26K | 161.97K | -143.37K | -830.55K | -1.24M |
| Income Before Tax Ratio | 0.00% | -351.57% | 0.00% | -3,540.48% | 0.00% | 6.11% | -13.89% | -158.20% | -707.33% |
| Income Tax Expense | 0.00 | 1.00 | -193.99K | 4.00 | -610.00 | -57.24K | -210.13K | 41.52K | 200.00 |
| Net Income | 0.00 | -2.95M | -78.21K | -1.11M | -727.65K | 219.21K | 66.76K | -872.06K | -1.24M |
| Net Income Ratio | 0.00% | -351.57% | 0.00% | -3,540.48% | 0.00% | 8.27% | 6.47% | -166.11% | -707.44% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -560.16 | 180.18 | -360.36 | -671.33 | -955.27 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -560.16 | 180.18 | -360.36 | -671.33 | -955.27 |
| Weighted Avg Shares Out | 0.00 | 23.84B | 4.84B | 4.40B | 1.30K | 1.30K | 1.30K | 1.30K | 1.30K |
| Weighted Avg Shares Out (Dil) | 0.00 | 23.84B | 4.84B | 4.40B | 1.30K | 1.30K | 1.30K | 1.30K | 1.30K |
Healthcare Expert, U.S. Army Veteran Rob Snyder Brings to Integrity Health Corporation (the “Company”) (OTC: FTEG) New Perspective on Disrupting Normalcy of Traditional Western Medicine
Integrity Health Corporation (OTC: FTEG) Proudly Acquires Medical Aesthetics Solutions (DBA Point Lumineux MedSpa)
Integrity Health Corporation (OTC: FTEG) Proudly Signs Letter of Intent with Vibrant MBS, LLC
Integrity Health Corporation Launches New Mission
Integrity Health Corporation Shareholders Update
Source: https://incomestatements.info
Category: Stock Reports